{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:05:17Z","timestamp":1768579517943,"version":"3.49.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s21981","type":"journal-article","created":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T00:36:15Z","timestamp":1346027775000},"page":"359","source":"Crossref","is-referenced-by-count":2,"title":["Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole"],"prefix":"10.2147","author":[{"given":"Paul","family":"Gordon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Corcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,8]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=13773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:24:19Z","timestamp":1477851859000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/amyotrophic-lateral-sclerosis-and-the-clinical-potential-of-dexpramipe-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s21981","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}